Literature DB >> 20509833

Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification.

Carlo M Camaggi1, Elena Zavatto, Laura Gramantieri, Valeria Camaggi, Elena Strocchi, Roberto Righini, Luca Merina, Pasquale Chieco, Luigi Bolondi.   

Abstract

BACKGROUND: Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) proteomic signature might be of interest for the early detection and staging of hepatocellular carcinoma (HCC). However, published procedures have been criticized for the lack of data about analytical reproducibility, and the use of inadequate data processing.
METHODS: MALDI-TOF profiling of peptides bound to serum albumin ("albuminome") was performed using 90 μL of serum from 45 study subjects (HCV-related cirrhosis, small, unifocal HCCs and advanced HCCs). To overcome the large intra-sample variability, a Quality Assurance protocol was implemented, and 4-8 samples for each subject were processed and analyzed. Overall, 522 subject samples and 299 quality-control spectra were analyzed. A machine-learning approach (Random Forest) was applied to analyze the data sets.
RESULTS: Mean intra-sample coefficient of variation (CV) of the analytical procedure was 17.6%-30.0%; inter-subject CV was in the range 48.8%-71.3% among the three study groups. The Random Forest procedure correctly classified 433/522 "patient samples" and 295/299 "reference samples"; 43/45 patients were correctly classified following this approach.
CONCLUSIONS: Our data suggest that, notwithstanding the large analytical variability found, multiple proteomic profiles obtained from each subject can differentiate cirrhosis with and without HCC, and HCCs with and without vascular invasion, warranting further investigation in a prospective setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20509833     DOI: 10.1515/CCLM.2010.248

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  7 in total

Review 1.  Systems Challenges of Hepatic Carcinomas: A Review.

Authors:  Dhatri Madduru; Johny Ijaq; Sujata Dhar; Saumyadip Sarkar; Naresh Poondla; Partha S Das; Silvia Vasquez; Prashanth Suravajhala
Journal:  J Clin Exp Hepatol       Date:  2018-05-17

Review 2.  Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients.

Authors:  Gul M Mustafa; Denner Larry; John R Petersen; Cornelis J Elferink
Journal:  World J Hepatol       Date:  2015-06-08

3.  A fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid.

Authors:  Ronald J Holewinski; Zhicheng Jin; Matthew J Powell; Matthew D Maust; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2013-01-29       Impact factor: 3.984

4.  Fast fixing and comprehensive identification to help improve real-time ligands discovery based on formaldehyde crosslinking, immunoprecipitation and SDS-PAGE separation.

Authors:  Lisi Zhu; Menglin Li; Lilong Wei; Xuejiao Liu; Jianrui Yin; Youhe Gao
Journal:  Proteome Sci       Date:  2014-02-01       Impact factor: 2.480

5.  Availability of MudPIT data for classification of biological samples.

Authors:  Dario Di Silvestre; Italo Zoppis; Francesca Brambilla; Valeria Bellettato; Giancarlo Mauri; Pierluigi Mauri
Journal:  J Clin Bioinforma       Date:  2013-01-14

6.  Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients.

Authors:  Paul Dowling; Valentina Palmerini; Michael Henry; Paula Meleady; Vincent Lynch; Jo Ballot; Giuseppe Gullo; John Crown; Michael Moriarty; Martin Clynes
Journal:  BBA Clin       Date:  2014-09-16

7.  Proteomic and network analysis of human serum albuminome by integrated use of quick crosslinking and two-step precipitation.

Authors:  Zhao Liu; Shuiming Li; Haiyang Wang; Min Tang; Mi Zhou; Jia Yu; Shunjie Bai; Pengfei Li; Jian Zhou; Peng Xie
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.